Article

Compilation of Potential Protein Targets for SARS-CoV-2: Preparation of Homology Model and Active Site Determination for Future Rational Antiviral Design

2020-04-06

Abstract excerpt

The recent pandemic due to the novel coronavirus SARS-CoV-2 (COVID-19) is causing significant mortality worldwide. However, there is a lack of specific drugs which can either prevent or treat the patient suffering from COVID-19. To understand the SARS-CoV-2 receptor recognition causing infectivity and pathogenesis, we have compiled a list of 20 probable drug targets on host and virus based on viral life cycle alon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 478ecf3f-472b-54a0-99ff-2be0bd4e85fe
DOI: 10.26434/chemrxiv.12084468.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Compilation of Potential Protein Targets for SARS-CoV-2: Preparation of Homology Model and Active Site Determination for Future Rational Antiviral DesignDOI 10.26434/chemrxiv.12084468.v1Read

A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sitesSemantic proximity Read

Structural biology of SARS-CoV-2: open the door for novel therapiesSemantic proximity Read

A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2Semantic proximity Read

In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2Semantic proximity Read

Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniquesSemantic proximity Read

Pharmacophore Analyses of SARS-CoV-2 Active Main Protease Inhibitors Using Pharmacophore Query and Docking StudySemantic proximity Read

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.Semantic proximity Read

Interaction of Drug Candidates with Various SARS-CoV‑2 Receptors: An in Silico Study to Combat COVID-19Semantic proximity Read

In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics SimulationsSemantic proximity Read

Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric VaccineSemantic proximity Read

Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2Semantic proximity Read

Druggable targets and therapeutic development for COVID-19Semantic proximity Read